GB1488522A - Powdered pharmaceutical preparations - Google Patents

Powdered pharmaceutical preparations

Info

Publication number
GB1488522A
GB1488522A GB4699374A GB4699374A GB1488522A GB 1488522 A GB1488522 A GB 1488522A GB 4699374 A GB4699374 A GB 4699374A GB 4699374 A GB4699374 A GB 4699374A GB 1488522 A GB1488522 A GB 1488522A
Authority
GB
United Kingdom
Prior art keywords
emulsion
water
oil
pharmaceutically acceptable
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4699374A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP48121930A external-priority patent/JPS582928B2/ja
Priority claimed from JP48121929A external-priority patent/JPS582927B2/ja
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of GB1488522A publication Critical patent/GB1488522A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
GB4699374A 1973-10-30 1974-10-30 Powdered pharmaceutical preparations Expired GB1488522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP48121930A JPS582928B2 (ja) 1973-10-30 1973-10-30 粉末製品の製造法
JP48121929A JPS582927B2 (ja) 1973-10-30 1973-10-30 フンマツセイヒンノ セイゾウホウ

Publications (1)

Publication Number Publication Date
GB1488522A true GB1488522A (en) 1977-10-12

Family

ID=26459174

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4699374A Expired GB1488522A (en) 1973-10-30 1974-10-30 Powdered pharmaceutical preparations

Country Status (4)

Country Link
CA (1) CA1047924A (fr)
DE (1) DE2451568A1 (fr)
FR (1) FR2257267B1 (fr)
GB (1) GB1488522A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933192A (en) * 1986-03-27 1990-06-12 Unilever Patent Holdings B.V. Hydratable powders which form WOW emulsions
WO2010039036A1 (fr) * 2008-10-01 2010-04-08 Friesland Brands B.V. Double émulsion et procédé de production associé
US8685455B2 (en) 2005-03-31 2014-04-01 Suntory Holdings Limited Oil-in-water emulsions containing lignan-class compounds and compositions containing the same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4655941A (en) * 1984-02-13 1987-04-07 Tomita Pharmaceutical Corp., Ltd. Method of preparing mixed electrolyte powder for bicarbonate dialysis and powder mixture formed
IL78930A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration
CN101856018B (zh) * 2010-06-18 2011-11-23 冀京民 醚菊酯可乳化粉剂及制造方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933192A (en) * 1986-03-27 1990-06-12 Unilever Patent Holdings B.V. Hydratable powders which form WOW emulsions
US8685455B2 (en) 2005-03-31 2014-04-01 Suntory Holdings Limited Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
WO2010039036A1 (fr) * 2008-10-01 2010-04-08 Friesland Brands B.V. Double émulsion et procédé de production associé
AU2009300494B2 (en) * 2008-10-01 2014-06-12 Friesland Brands B.V. Double emulsion and method to produce such

Also Published As

Publication number Publication date
CA1047924A (fr) 1979-02-06
FR2257267A1 (fr) 1975-08-08
FR2257267B1 (fr) 1979-07-27
DE2451568A1 (de) 1975-05-07

Similar Documents

Publication Publication Date Title
CA1333153C (fr) Emulsion aqueuse pour forme galenique
KR830002327A (ko) 약학적 제제
GB8318396D0 (en) Corticoid-containing preparations
CA2039456A1 (fr) Appareil de dosage osmotique pour l'administration de medicaments liquides
DK233080A (da) Overtraeksmiddel til foedevarer og medicinalvarer fremgangsmaade til fremstilling deraf samt produkter forsynet med et saadant overtraek
ZA912793B (en) Pharmaceutical formulations
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
WO1994023688A3 (fr) Preparations topiques cosmetiques et medicales
DE69535127D1 (de) Emulgierte arzneistoffabgabesysteme
ATE100708T1 (de) Unbeschichtete pharmazeutische reaktionstablette.
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
CA2274773A1 (fr) Agents therapeutiques aqueux a base d'ibuprofene
NO175564C (no) Fremgangsmåte for fremstilling av et peroralt, osmotisk virkende system for tungtopplöselige terapeutiske stoffer
NO172423C (no) Fremgangsmaate for fremstilling av et brusende farmasoeytisk pulver- eller tablettpreparat inneholdende ibuprofen
DE69919713D1 (de) Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium
WO1999056727A3 (fr) Systemes d'apport de medicament de preconcentre de microemulsion et d'emulsion depourvues de solvant/cosolvant
IE871584L (en) Sustained release capsule.
FR2707184B1 (fr) Procédé de préparation de sphérules contenant un principe actif alimentaire ou pharmaceutique.
GB1488522A (en) Powdered pharmaceutical preparations
GR3032113T3 (en) Solid and liquid solutions of drugs which are not readily soluble in water.
DE3538040A1 (de) Vorrichtung zur verabreichung eines wirkstoffs an das kolon
NO922084D0 (no) Lipid-formuleringssystem
IE891919L (en) Pharmaceutical dosage form for the medication of fish
AU559377B2 (en) Saponin emulsified vitamin e aqueous solution
CA2028234A1 (fr) Enduit cellulosique

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee